Sign in

CIK 0001372299

  • Non-accelerated filer
  • Smaller reporting company

Ocugen, Inc.

Sign in to watch
Ticker
OCGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 484-328-4701
Business address
11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
Former names
HISTOGENICS CORP
  1. 4 Open-market sale Chief Executive Officer sold 100,000 shares at $1.66 ($166,000)
  2. 4 Open-market sale Director sold 4,500 shares at $1.83 ($8,235)
  3. 4 Open-market sale Director sold 42,000 shares at $2.91 ($122,220)
  4. 4 Open-market sale Director sold 7,500 shares at $2.57 ($19,275)
  5. 4 Open-market sale Chief Executive Officer sold 150,000 shares at $2.72 ($408,000)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market sale Chief Executive Officer sold 125,000 shares at $1.92 ($240,000)
  13. 4 Open-market sale Director sold 7,500 shares at $2.83 ($21,225)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award CAO/SVP, Finance acquired 22,940 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale Chief Executive Officer sold 81,823 shares at $2.65 ($216,831)
  19. 4 Option exercise Director acquired 88,000 shares (option exercise)
  20. 4 Open-market sale Chief Executive Officer sold 90,000 shares at $3.74 ($336,600)

Page 4 of 15 · 288 filings